NextCure hires Cel­gene vet as CMO; José Ve­ga leaves Mer­ck to be­come Mod­er­na's chief safe­ty of­fi­cer

NextCure has found its new CMO af­ter the pre­vi­ous ex­ec­u­tive re­signed last Au­gust.

Han Myint, a bio­phar­ma and acad­e­mia vet­er­an of more than 20 years, joined the com­pa­ny Thurs­day af­ter serv­ing as CMO at Nex­Im­mune for a lit­tle over a year. Myint had over­seen the com­pa­ny’s Phase I/II tri­al for a cell ther­a­py in acute myeloid leukemia be­fore hop­ping over to NextCure.

“Han’s strong in­dus­try track record is high­light­ed by his in­volve­ment in the de­vel­op­ment of mul­ti­ple U.S. Food and Drug ap­proved prod­ucts,” CEO Michael Rich­man said in a state­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.